- Home
- Publications
- Publication Search
- Publication Details
Title
Current and future therapies for type 1 diabetes
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-19
DOI
10.1007/s00125-021-05398-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents
- (2020) Christine Ferrara-Cook et al. DIABETES CARE
- SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action
- (2020) Milton Packer DIABETES CARE
- Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
- (2020) Nicklas J Johansen et al. Lancet Diabetes & Endocrinology
- Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial
- (2020) Husam Ghanim et al. DIABETES OBESITY & METABOLISM
- The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: analysis of LEADER and SUSTAIN 6 trials
- (2020) Lawrence A. Leiter et al. DIABETES OBESITY & METABOLISM
- Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming
- (2020) Adrian Villalba et al. Frontiers in Endocrinology
- 3-LB: Golimumab (GLM) Preserves ß-Cell Function and Reduces Insulin Use and Hypoglycemia in Children and Young Adults with Recently Diagnosed Type 1 Diabetes (T1D): The Phase 2 T1GER Study
- (2020) TERESA QUATTRIN et al. DIABETES
- Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
- (2020) Michelle Rosenzwajg et al. DIABETOLOGIA
- Current progress in stem cell therapy for type 1 diabetes mellitus
- (2020) Shuai Chen et al. Stem Cell Research & Therapy
- Adjunct Therapies in Treatment of Type 1 Diabetes
- (2020) Itivrita Goyal et al. Journal of Diabetes
- Long-term viability through selective permeability
- (2020) Ken Coppieters et al. Nature Biomedical Engineering
- The impact of pharmacological and lifestyle interventions on body weight in people with type 1 diabetes: A systematic review and meta‐analysis
- (2020) Saniya Tandon et al. DIABETES OBESITY & METABOLISM
- Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?
- (2020) Roberto Mallone et al. DIABETOLOGIA
- The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes
- (2020) Christine Bender et al. Science Advances
- An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
- (2020) Liliane Khoryati et al. Science Immunology
- Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
- (2020) Bart O. Roep et al. Nature Reviews Endocrinology
- International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated with Sodium-Glucose Cotransporter (SGLT) Inhibitors
- (2019) Thomas Danne et al. DIABETES CARE
- Excess Cardiovascular Risk in Type 1 Diabetes Mellitus
- (2019) John R. Petrie et al. CIRCULATION
- Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
- (2019) Michael J. Haller et al. DIABETES
- SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution
- (2019) Joseph I. Wolfsdorf et al. DIABETES CARE
- Targeting Interleukin-6 Signaling in Clinic
- (2019) Sujin Kang et al. IMMUNITY
- Cardiovascular Risk in Type 1 Diabetes Mellitus
- (2019) Jonathan Schofield et al. Diabetes Therapy
- 233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7
- (2019) KATHERINE R. TUTTLE et al. DIABETES
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
- (2019) Anette-Gabriele Ziegler et al. BMJ Open
- WITHDRAWN: IDF Diabetes Atlas: Worldwide Estimates of Incidence, Prevalence and Mortality of Type 1 Diabetes in Children and Adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Christopher C. Patterson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
- (2019) Brendon L Neuen et al. Lancet Diabetes & Endocrinology
- Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
- (2019) Manuela Battaglia et al. DIABETES CARE
- Advances in technology for management of type 1 diabetes
- (2019) Roy W Beck et al. LANCET
- IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes
- (2019) Sakthi Rajendran et al. CLINICAL IMMUNOLOGY
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial
- (2019) Thomas F. Dejgaard et al. DIABETES OBESITY & METABOLISM
- Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes
- (2019) Somayeh Sabouri et al. JOURNAL OF AUTOIMMUNITY
- SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks
- (2019) Simeon I Taylor et al. Lancet Diabetes & Endocrinology
- Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance
- (2018) Eddie A. James et al. DIABETES
- Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
- (2018) John B. Buse et al. DIABETES CARE
- Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1cin New-Onset Type 1 Diabetes
- (2018) Michael J. Haller et al. DIABETES CARE
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
- (2018) Chantal Mathieu et al. DIABETES CARE
- A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials
- (2018) Vanita R. Aroda DIABETES OBESITY & METABOLISM
- Obesity and diabetes-Not only a simple link between two epidemics
- (2018) Agata Chobot et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Verapamil and beta cell function in adults with recent-onset type 1 diabetes
- (2018) Fernando Ovalle et al. NATURE MEDICINE
- Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
- (2018) Emma L. Smith et al. Frontiers in Immunology
- Enteroviral Infections as a Trigger for Type 1 Diabetes
- (2018) Teresa Rodriguez-Calvo Current Diabetes Reports
- Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention
- (2018) Sarah J Richardson et al. CURRENT OPINION IN PHARMACOLOGY
- Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study
- (2018) Matthew C. Riddle et al. DIABETES CARE
- Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact and Mechanisms
- (2018) Karen D Corbin et al. ENDOCRINE REVIEWS
- Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
- (2018) Araz Rawshani et al. LANCET
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
- (2018) Paresh Dandona et al. DIABETES CARE
- Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
- (2018) Julio Rosenstock et al. DIABETES CARE
- Addition of GLP‐1RA therapy to Insulin in C‐peptide Positive Patients With Type 1 Diabetes
- (2018) Nitesh D Kuhadiya et al. DIABETES OBESITY & METABOLISM
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- The challenge of modulating β-cell autoimmunity in type 1 diabetes
- (2018) Mark A Atkinson et al. Lancet Diabetes & Endocrinology
- Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
- (2018) Bart O Roep et al. Lancet Diabetes & Endocrinology
- Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
- (2018) Jordan Rowlands et al. Frontiers in Endocrinology
- Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Autoreactive T cells in type 1 diabetes
- (2017) Alberto Pugliese JOURNAL OF CLINICAL INVESTIGATION
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
- (2017) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intralymphatic Injection of Autoantigen in Type 1 Diabetes
- (2017) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
- (2017) Satish K. Garg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
- (2017) John R Petrie et al. Lancet Diabetes & Endocrinology
- Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2017) Weihao Wang et al. Diabetes Therapy
- Type 1 diabetes mellitus
- (2017) Anastasia Katsarou et al. Nature Reviews Disease Primers
- T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes
- (2017) Adam L. Burrack et al. Frontiers in Endocrinology
- Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2017) Weihao Wang et al. Diabetes Therapy
- The viral paradigm in type 1 diabetes: Who are the main suspects?
- (2016) Teresa Rodriguez-Calvo et al. AUTOIMMUNITY REVIEWS
- Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2
- (2016) Connor J. Dwyer et al. Current Diabetes Reports
- Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
- (2016) Bo Ahrén et al. DIABETES CARE
- Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
- (2016) Chantal Mathieu et al. DIABETES CARE
- Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries
- (2016) Ruth S. Weinstock et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Genetic risk factors for type 1 diabetes
- (2016) Flemming Pociot et al. LANCET
- Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes
- (2016) Jenny Aurielle B Babon et al. NATURE MEDICINE
- Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression
- (2016) Christian Hundhausen et al. Science Translational Medicine
- Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
- (2016) John A. Todd et al. PLOS MEDICINE
- Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
- (2016) Thomas Fremming Dejgaard et al. Lancet Diabetes & Endocrinology
- Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study
- (2015) Christian S. Frandsen et al. DIABETES CARE
- Efficacy and Safety of Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes
- (2015) Robert R. Henry et al. DIABETES CARE
- Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
- (2015) Anne L. Peters et al. DIABETES CARE
- Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes
- (2015) Ezio Bonifacio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes
- (2015) Ingrid M. Libman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SGLT2 Inhibitors May Predispose to Ketoacidosis
- (2015) Simeon I. Taylor et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
- (2015) Mark R. Rigby et al. JOURNAL OF CLINICAL INVESTIGATION
- Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis
- (2015) Amelia K. Linnemann et al. MOLECULAR ENDOCRINOLOGY
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study
- (2014) Kamlesh Khunti et al. DIABETES CARE
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
- (2014) Ronnie Aronson et al. DIABETES CARE
- Autoimmune Aspects of Type 2 Diabetes Mellitus - A Mini-Review
- (2014) Bianca K. Itariu et al. GERONTOLOGY
- B Lymphocyte Depletion by CD20 Monoclonal Antibody Prevents Diabetes in Nonobese Diabetic Mice despite Isotype-Specific Differences in Fc R Effector Functions
- (2014) Y. Xiu et al. JOURNAL OF IMMUNOLOGY
- Progress in immune-based therapies for type 1 diabetes
- (2013) M. von Herrath et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- (2013) W. Hagopian et al. DIABETES
- Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
- (2013) K. Timper et al. DIABETES CARE
- B-Lymphocyte Depletion With Rituximab and -Cell Function: Two-Year Results
- (2013) M. D. Pescovitz et al. DIABETES CARE
- Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
- (2013) Tihamer Orban et al. DIABETES CARE
- Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
- (2013) Andrew E. Hogan et al. DIABETOLOGIA
- Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?
- (2013) S. J. Cleland et al. DIABETOLOGIA
- Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes
- (2013) Jing Lu Kroll et al. JOURNAL OF CLINICAL VIROLOGY
- Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells
- (2013) Young-Sun Lee et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
- (2013) Stephen E Gitelman et al. Lancet Diabetes & Endocrinology
- Preventing -Cell Loss and Diabetes With Calcium Channel Blockers
- (2012) G. Xu et al. DIABETES
- Improvements in the Life Expectancy of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study Cohort
- (2012) R. G. Miller et al. DIABETES
- Interleukin-21 Receptor-Mediated Signals Control Autoreactive T Cell Infiltration in Pancreatic Islets
- (2012) Tom L. Van Belle et al. IMMUNITY
- Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?
- (2011) Urs Christen et al. Cellular & Molecular Immunology
- Interleukin-21 Is Critically Required in Autoimmune and Allogeneic Responses to Islet Tissue in Murine Models
- (2011) Helen M. McGuire et al. DIABETES
- How Does Type 1 Diabetes Develop?: The Notion of Homicide or -Cell Suicide Revisited
- (2011) M. A. Atkinson et al. DIABETES
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- The use of metformin in type 1 diabetes: a systematic review of efficacy
- (2010) S. Vella et al. DIABETOLOGIA
- Autologous Hematopoietic Stem Cell Transplantation for Type 1 Diabetes
- (2009) Júlio C. Voltarelli et al. Annals of the New York Academy of Sciences
- Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients
- (2009) B. Keymeulen et al. BLOOD
- Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD Mice
- (2009) A. P.R. Sutherland et al. DIABETES
- Effects of Exenatide Alone and in Combination With Daclizumab on -Cell Function in Long-Standing Type 1 Diabetes
- (2009) K. I. Rother et al. DIABETES CARE
- Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study
- (2009) L. Mastrandrea et al. DIABETES CARE
- The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes
- (2009) T J Wilkin INTERNATIONAL JOURNAL OF OBESITY
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth Study
- (2009) Lenna L Liu et al. PEDIATRIC DIABETES
- Concordance for Islet Autoimmunity among Monozygotic Twins
- (2008) Maria J. Redondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study
- (2008) Søren Søgaard Lund et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started